Is there a cloud in the silver lining for imatinib?

por Paterson, S C, Smith, K D, Holyoake, T L, Jørgensen, H G
Publicado 2003

Early detection of tumour immune-rejection using magnetic resonance imaging

por Hu, D-E, Beauregard, D A, Bearchell, M C, Thomsen, L L, Brindle, K M
Publicado 2003

Delayed infection, late tonsillectomy or adenoidectomy and adult leukaemia: a case–control study

por Vineis, P, Miligi, L, Crosignani, P, Davico, L, Fontana, A, Masala, G, Nanni, O, Ramazzotti, V, Rodella, S, Stagnaro, E, Tumino, R, Viganò, C, Vindigni, C, Costantini, A S
Publicado 2003

Phenytoin toxicity due to fluoropyrimidines (5FU/capecitabine): three case reports

por Brickell, K, Porter, D, Thompson, P
Publicado 2003

The effect of deprivation and the systemic inflammatory response on outcome following curative resection for colorectal cancer

por McMillan, D C, Canna, K, McArdle, C S
Publicado 2003

Glomeruloid microvascular proliferation is associated with p53 expression, germline BRCA1 mutations and an adverse outcome following breast cancer

por Goffin, J R, Straume, O, Chappuis, P O, Brunet, J-S, Bégin, L R, Hamel, N, Wong, N, Akslen, L A, Foulkes, W D
Publicado 2003

Evaluation of cumulative prognostic scores based on the systemic inflammatory response in patients with inoperable non-small-cell lung cancer

por Forrest, L M, McMillan, D C, McArdle, C S, Angerson, W J, Dunlop, D J
Publicado 2003

Short communication: A33scFv–cytosine deaminase: a recombinant protein construct for antibody-directed enzyme-prodrug therapy

por Deckert, P M, Renner, C, Cohen, L S, Jungbluth, A, Ritter, G, Bertino, J R, Old, L J, Welt, S
Publicado 2003

Genetic alterations in the coding region of the bak gene in uterine cervical carcinoma

por Wani, K M Y, Huilgol, N G, Hongyo, T, Shah, H Ryo K, Chatterjee, N, Nair, C K K, Nomura, T
Publicado 2003

Cancer and the FRA3B/FHIT fragile locus: it's a HIT

por Huebner, K, Croce, C M
Publicado 2003

Modulation of erlotinib pharmacokinetics in mice by a novel cytochrome P450 3A4 inhibitor, BAS 100

por Smith, N F, Baker, S D, Gonzalez, F J, Harris, J W, Figg, W D, Sparreboom, A
Publicado 2008

Quantitative techniques in (18)FDG PET scanning in oncology

por Castell, F, Cook, G J R
Publicado 2008

Diagnostic, prognostic and therapeutic implications of carbonic anhydrases in cancer

por Potter, C P S, Harris, A L
Publicado 2003

Surrogate markers in antiangiogenesis clinical trials

por Davis, D W, McConkey, D J, Abbruzzese, J L, Herbst, R S
Publicado 2003

A phase II trial of bryostatin-1 administered by weekly 24-hour infusion in recurrent epithelial ovarian carcinoma

por Clamp, A R, Blackhall, F H, Vasey, P, Soukop, M, Coleman, R, Halbert, G, Robson, L, Jayson, G C
Publicado 2003

Infection with Kaposi's sarcoma-associated herpesvirus (KSHV) and human immunodeficiency virus (HIV) in relation to the risk and clinical presentation of Kaposi's sarcoma in Uganda

por Newton, R, Ziegler, J, Bourboulia, D, Casabonne, D, Beral, V, Mbidde, E, Carpenter, L, Parkin, D M, Wabinga, H, Mbulaiteye, S, Jaffe, H, Weiss, R, Boshoff, C
Publicado 2003

Extended duration of the detectable stage by adding HPV test in cervical cancer screening

por van den Akker-van Marie, M E, van Ballegooijen, M, Rozendaal, L, Meijer, C J L M, Habbema, J D F
Publicado 2003

Cancer treatment with kinase inhibitors: what have we learnt from imatinib?

por Ross, D M, Hughes, T P
Publicado 2004

Risk of malignant lymphoma associated with human herpesvirus-8: a case–control study in Spain

por de Sanjosé, S, Goedert, J J, Marshall, V, Bellas, C, Benavente, Y, Bosch, R, Domingo, A, Fernandez de Sevilla, A, Servitje, O, Whitby, D
Publicado 2004

Fatal outcome of a hypersensitivity reaction to paclitaxel: a critical review of premedication regimens

por Kloover, J S, Bakker, M A den, Gelderblom, H, Meerbeeck, J P van
Publicado 2004